Jupiter Topco LLC Invests $544.25 Million in Corteva, Inc. $CTVA

Jupiter Topco LLC acquired a new stake in Corteva, Inc. (NYSE:CTVAFree Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,426,384 shares of the company’s stock, valued at approximately $544,246,000. Jupiter Topco LLC owned 0.96% of Corteva as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in CTVA. Arbejdsmarkedets Tillaegspension acquired a new position in Corteva during the fourth quarter worth about $23,679,000. Bank of New York Mellon Corp acquired a new stake in shares of Corteva in the second quarter valued at approximately $392,447,000. Leonteq Securities AG purchased a new position in shares of Corteva during the 4th quarter worth approximately $2,350,000. Brandes Investment Partners LP increased its stake in shares of Corteva by 1.1% during the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after purchasing an additional 24,985 shares in the last quarter. Finally, Twin Capital Management Inc. raised its position in shares of Corteva by 178.9% during the 4th quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock worth $1,702,000 after purchasing an additional 16,288 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 0.4%

Shares of Corteva stock opened at $83.18 on Wednesday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97. The business’s fifty day moving average is $82.39 and its two-hundred day moving average is $80.37. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a market cap of $55.50 billion, a PE ratio of 55.09, a P/E/G ratio of 2.54 and a beta of 0.57.

Corteva (NYSE:CTVAGet Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue was down 1.2% on a year-over-year basis. During the same period in the prior year, the firm posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio is presently 47.68%.

Analyst Ratings Changes

CTVA has been the topic of a number of analyst reports. CICC Research increased their target price on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. JPMorgan Chase & Co. upped their price objective on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Mizuho lifted their price objective on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Barclays boosted their target price on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Finally, Bank of America upped their target price on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $91.50.

Get Our Latest Analysis on CTVA

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.